台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

PD02-04: Immediate assessment of spermatogenesis at testicular biopsy for azoospermic males using touch print smear

2024-01-10 • 觀看: 618 • 回應: 0 • doc
PD02-03: Navigating the obesity paradox in bladder cancer prognosis – insights from the Taiwan national health insurance system database

2024-01-10 • 觀看: 620 • 回應: 0 • doc
PD02-02: Lenvatinib enhances Cisplatin sensitivity, induces apoptosis and inhibits metastasis in bladder cancer cells through inactivation of EGFR/ERK/P-38/NF-κB signaling

2024-01-10 • 觀看: 691 • 回應: 0 • doc
PD02-01: External validation of a new Taiwanese prostate cancer risk calculator within another medical centre

2024-01-10 • 觀看: 639 • 回應: 0 • doc
PD01-06: Retroperitoneal laparoscopic adrenalectomy for large adrenal tumors—analysis of tumor size and adverse events: A retrospective single-center study

2024-01-10 • 觀看: 606 • 回應: 0 • doc
PD01-05: ChatGPT-4 as a tool for patient education: artificial intelligence and urological cancer-related queries

2024-01-10 • 觀看: 631 • 回應: 0 • doc
PD01-04: Study on the pro-tumor function of UBE2C gene in metastatic prostate cancer and tts potential as a therapeutic marker

2024-01-10 • 觀看: 608 • 回應: 0 • doc
PD01-03: Neoadjuvant therapy in initially inoperable upper tract urothelial carcinoma – a comparative study with adjuvant strategies

2024-01-10 • 觀看: 640 • 回應: 0 • doc
PD01-02: Knockdown of EPS8 expression may attenuate disease progression in enzalutamide-resistant prostate cancer

2024-01-10 • 觀看: 677 • 回應: 0 • doc
PD01-01: Safety and efficacy of enzalutamide by ereatment duration in the Asian subgroup from ARCHES: A post hoc analysis

2024-01-10 • 觀看: 1138 • 回應: 0 • doc
19 青年事務委員會

2024-01-02 • 觀看: 22 • 回應: 0 • pdf
18 醫療政策暨公共事務委員會

2024-01-02 • 觀看: 11 • 回應: 0 • pdf

Prev
160
161
162
163
164
165
166
167
168
169
Next
/ 1056